scholarly journals Mode of Action Analyses of Neferine, a Bisbenzylisoquinoline Alkaloid of Lotus (Nelumbo nucifera) against Multidrug-Resistant Tumor Cells

2017 ◽  
Vol 8 ◽  
Author(s):  
Onat Kadioglu ◽  
Betty Y. K. Law ◽  
Simon W. F. Mok ◽  
Su-Wei Xu ◽  
Thomas Efferth ◽  
...  
2021 ◽  
Vol 1 (1) ◽  
pp. 55-68
Author(s):  
Urszula Smietanka ◽  
Małgorzata Szostakowska-Rodzos ◽  
Sylwia Tabor ◽  
Anna Fabisiewicz ◽  
Ewa A. Grzybowska

Circulating tumor cells (CTCs) are gaining momentum as a diagnostic tool and therapeutic target. CTC clusters are more metastatic, but harder to study and characterize, because they are rare and the methods of isolation are mostly focused on single CTCs. This review highlights the recent advances to our understanding of tumor cell clusters with the emphasis on their composition, origin, biology, methods of detection, and impact on metastasis and survival. New approaches to therapy, based on cluster characteristics are also described.


Author(s):  
Lohanathan Bharathi Priya ◽  
Chih‐Yang Huang ◽  
Rouh‐Mei Hu ◽  
Balamuralikrishnan Balasubramanian ◽  
Rathinasamy Baskaran

Author(s):  
Monica Notarbartolo ◽  
Melchiorre Cervello ◽  
Paola Poma ◽  
Luisa Dusonchet ◽  
Maria Meli ◽  
...  

2000 ◽  
Vol 53 (10) ◽  
pp. 1201-1206 ◽  
Author(s):  
MUN-CHUAL RHO ◽  
MASAHIKO HAYASHI ◽  
AKIKO FUKAMI ◽  
RIKA OBATA ◽  
TOSHIAKI SUNAZUKA ◽  
...  

Author(s):  
Elise A. Lamont ◽  
Nicholas A. Dillon ◽  
Anthony D. Baughn

SUMMARY Pyrazinamide (PZA) is a cornerstone antimicrobial drug used exclusively for the treatment of tuberculosis (TB). Due to its ability to shorten drug therapy by 3 months and reduce disease relapse rates, PZA is considered an irreplaceable component of standard first-line short-course therapy for drug-susceptible TB and second-line treatment regimens for multidrug-resistant TB. Despite over 60 years of research on PZA and its crucial role in current and future TB treatment regimens, the mode of action of this unique drug remains unclear. Defining the mode of action for PZA will open new avenues for rational design of novel therapeutic approaches for the treatment of TB. In this review, we discuss the four prevailing models for PZA action, recent developments in modulation of PZA susceptibility and resistance, and outlooks for future research and drug development.


1990 ◽  
Vol 81 (11) ◽  
pp. 1155-1161 ◽  
Author(s):  
Yuji Heike ◽  
Hirofumi Hamada ◽  
Noriaki Inamura ◽  
Saburo Sone ◽  
Takeshi Ogura ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document